<DOC>
	<DOCNO>NCT00908778</DOCNO>
	<brief_summary>The purpose study determine safety efficacy Vitreosolve® diabetic retinopathy patient .</brief_summary>
	<brief_title>A Safety Efficacy Study Vitreosolve® Non-Proliferative Diabetic Retinopathy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Detachment</mesh_term>
	<criteria>Subjects history systemic diabetes ( type I , II ) Subject document history Non proliferative Diabetic Retinopathy ( NPDR ) Subjects partial PVD baseline exam study eye . Subjects retinal pathology study eye ( NPDR ) Subjects high myopia study eye Subjects monocular vision central lateral vision 20/200 bad BCVA nonstudy eye . Subjects aphakic study eye pseudophakic , cataract extraction surgery le 6 month prior study enrollment . Subjects either vitrectomy surgery , intavitreal injection , laser treatment study eye .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
</DOC>